
Fractional shares
Get dividend payments
Curaleaf Holdings Inc (CURLF) is a publicly traded drug manufacturers - specialty and generic business based in the US which employs around 5,500 staff. Curaleaf Holdings is listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and traded in US dollars. Its current price of $0.95 is 5.0% down on its price a month ago ($1.00).
To make comparing even easier we came up with the Finder Score. Costs, features, ease and range of investments across 30+ platforms are all weighted and scaled to produce a score out of 10. The higher the score the better the platform – simple.
Read the full methodologyAll investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Curaleaf Holdings), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Curaleaf Holdings is a major part of the OTCQX, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Curaleaf Holdings's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of $0.954
1 week (2025-04-21) | 11.84% |
---|---|
1 month (2025-03-28) | -4.60% |
3 months (2025-01-28) | -23.68% |
6 months (2024-10-28) | -67.66% |
1 year (2024-04-28) | -80.92% |
2 years (2023-04-28) | -62.73% |
3 years (2022-04-28) | -83.76% |
5 years (2020-04-28) |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Curaleaf Holdings P/E ratio, PEG ratio and EBITDA.
Curaleaf Holdings's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Curaleaf Holdings's shares trade at around 0x recent earnings.
Curaleaf Holdings's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give None. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Curaleaf Holdings's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Curaleaf Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $253.4 million (£190.1 million).
The EBITDA is a measure of Curaleaf Holdings's overall financial performance and is widely used to measure a its profitability.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.
Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Ever wondered how to buy shares in Walgreens? We explain how and compare a range of providers that can give you access to many brands, including Walgreens.
Ever wondered how to buy shares in Medtronic? We explain how and compare a range of providers that can give you access to many brands, including Medtronic.
Find out how to buy shares in Spire Healthcare, see Spire Healthcare’s share prices over the last three months and check out our must-do checklist if you’re looking to invest.